Brughera Marco Maria exercised Options for 15,545 FENNEC PHARMACEUTICALS shares at $2.11 per share and recorded a same-day sale at $10.29 per share. The transactions show investors how the insider’s common-share and derivative-security holdings changed, including 220,000 derivative securities after the option exercise.
Key Highlights
- Brughera Marco Maria sold 15,545 FENNEC PHARMACEUTICALS shares at $10.29 per share.
- The insider held 220,000 derivative securities after exercising options, representing about 6.6% of the prior derivative holding.
- The option exercise and share sale were recorded on 15 September 2026 under transaction codes M and S.
Brughera Marco Maria exercised options for 15,545 FENNEC PHARMACEUTICALS INC. (NASDAQ: FENC) shares at $2.11 per share, with the resulting record showing ownership of 15,545 shares. The transaction was dated 15 September 2026 and classified under SEC transaction code M.
Same-Day Sale at $10.29 Per Share
A separate entry on 15 September 2026 recorded Brughera’s sale of 15,545 FENNEC PHARMACEUTICALS shares at $10.29 per share. The transaction carried SEC code S, which identifies an open-market sale. The post-transaction record showed 0 shares, and the sale represented about 100.0% of Brughera’s prior shares holding. The same date also included an option exercise involving 15,545 derivative securities. Brughera’s resulting holding stood at 220,000 derivative securities.
Common Shares and Derivative Securities Reported Separately
The records distinguish between the common shares sold and the derivative securities held after the option exercise. The derivative-securities transaction represented about 6.6% of Brughera’s prior derivative securities holding. The M code identifies the option-exercise entries, while the S code identifies the share-sale entry. Transaction code M denotes the exercise or conversion of a derivative security.
FAQs
Q: What did Brughera Marco Maria do in the Fennec Pharmaceuticals insider transaction?
A: Brughera Marco Maria exercised options for Fennec Pharmaceuticals shares and recorded a same-day sale. The transactions involved 15,545 shares.
Q: At what price did the Fennec Pharmaceuticals insider sell shares?
A: Brughera Marco Maria sold the Fennec Pharmaceuticals shares at $10.29 per share. The post-sale record showed 0 shares.
Q: How many derivative securities did Brughera Marco Maria hold afterward?
A: Brughera Marco Maria held 220,000 Fennec Pharmaceuticals derivative securities after the option exercise. The transaction represented about 6.6% of the prior derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.